RecruitingNot Applicable

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

China500 participantsStarted 2026-03-11

Plain-language summary

The study is designed to collect magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, CT images, and histopathology results to establish a database for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female participants aged ≥ 18 years
✓. Patients with early upper gastrointestinal cancer referred for endoscopic submucosal dissection (ESD), or patients with upper gastrointestinal precancerous lesions or precancerous conditions referred for biopsy by esophagogastroduodenoscopy (EGD)
✓. Participants who are willing and able to participate in this study, complete all required examinations and follow-up visits, and who have provided written informed consent

Exclusion criteria

✕. Patients who are not eligible for surgery or who refuse any abdominal surgery in case of capsule retention and endoscopic retrieval failure
✕. Patients with cardiac pacemaker or other implanted electromedical devices which could interfere with magnetic resonance
✕. Suspected or known intestinal stenosis or other known risk factors for capsule retention
✕. Patients with dysphagia
✕. Pregnancy
✕. Allergy to polymeric materials, latex, simethicone, or pronase
✕. Patients plan to undergo magnetic resonance imaging examination before excretion of the capsule
✕. Patients with any condition that precludes compliance with the study

What they're measuring

Magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, and CT images

Timeframe: Prior to ESD or biopsy

Histopathology results

Timeframe: During ESD or biopsy

Trial details

NCT IDNCT07462247

SponsorChanghai Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12

Contact for this trial

Jun Pan, MD

+86-13764598567 panjun059@163.com

View on ClinicalTrials.gov More Upper Gastrointestinal Cancer trials